SEHK:455Pharmaceuticals
Tianda Pharmaceuticals First Half 2025 Earnings: HK$0.015 loss per share (vs HK$0.013 loss in 1H 2024)
Tianda Pharmaceuticals ( HKG:455 ) First Half 2025 Results Key Financial Results Revenue: HK$136.6m (down 13% from 1H...
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.